Rep. Joe Neguse, D-Colo., vice chairman of the subcommittee, is calling for a hearing to probe federal enforcers' approach to evaluating pharmaceutical mergers.
The agency has challenged 67 pharmaceutical mergers worth over $900 billion since 1994, according to data compiled by the American Antitrust Institute for a September report.
"It would be one thing if the acquisitions resulted in deterring future anticompetitive conduct anddecreased drug prices for consumers.
The Covid-19 pandemic has called attention to existing concerns of rising drug prices and reduced innovation, Neguse wrote the committee leaders.
WATCH: Here's why some experts are calling for a breakup of Big Tech after the House antitrust report
Joe Neguse, Jerrold Nadler, David Cicilline, Neguse, Rohit Chopra, Rebecca Kelly Slaughter, Chopra, Christine Wilson
Apple, Facebook, Google, Big Pharma, CNBC, Big Tech, Federal Trade, Democratic, American Antitrust Institute, Office, Allergan, Pfizer, Mylan, Republican, Federal Trade Commission, Merck, YouTube